Inhalational Anesthesia and Precipitation of Dementia: is There a Link?

NCT01903421 | Unknown

• 1 other identifier: 13-6122
• Study Type: interventional
• Target: 500
• Locations: 2 countries
• Sites: 3

Brief Summary

Many elderly patients undergoing surgical procedures already have impaired cognitive (memory/concentration) status. Patients with pre-existing cognitive impairment, or dementia, may benefit from modified anesthesia techniques. It is estimated that one in eight people age 65 and older has Alzheimers disease. More so, nearly half of people that are 85 years or older have Alzheimers disease. Currently, both spinal (regional) and inhalational (general) anesthesia, are used in patients undergoing common urological, orthopedic, and general surgical procedures. Inhalational anesthesia has been associated with higher risk of memory impairment in experimental (animal) and human studies. However, currently, there are simply no large or good enough studies to be sure that inhalational anesthesia is responsible for causing dementia and Alzheimers disease.The proposed study investigates if elderly patients (65 years and older) undergoing spinal anesthesia (patient is awake or slightly sedated) are less likely to develop dementia and Alzheimers disease for up to 2 years after surgery, when compared to inhalational anesthesia (patient is kept asleep with gas anesthetic). The investigators will also test all patients for the presence of apolipoprotein (ApoE-Îμ4 type of gene that is present in 15-20% of patients), and beta-amyloid tau protein (present in cerebrospinal fluid) that are known risk factors for Alzheimers disease. The particular strength of this study is that it takes into account whether the frequency and/or severity of dementia and Alzheimers disease is different in patients with and without these markers. The investigators believe that this study will make a major contribution to better understanding of development of Alzheimers disease.

Conditions

Alzheimer's Disease; Dementia

Keywords

Elderly surgical patients; Alzheimer's disease; Dementia; Elderly; Surgery

Outcome Measures

Primary Outcomes (1)

• Assessing the incidence of early dementia

  Change from baseline, hospital discharge (3 day average), 3 months, 1 year, and 2 years

Study Arms (2)

Spinal anesthesia group

ACTIVE COMPARATOR

Spinal anesthesia group will receive bupivacaine 10-15mg anesthesia according to the standard practice. Supplemental sedation with intravenous anesthetics (midazolam/propofol) will be optional.

Drug: Spinal anesthesia group: bupivacaine 10-15mg; Genetic: Blood test; Other: Lumbar spinal tap; Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE

General anesthesia group

ACTIVE COMPARATOR

Induction of anesthesia will be achieved with propofol 1.5-2mg/kg and fentanyl 1-3g/kg. Anesthesia will be maintained with inhalational anesthesia (isoflurane or sevoflurane) at the discretion of anesthesiologist in charge of the case. A mixture of Air/O2 will be used to maintain adequate oxygenation. Nitrous oxide will not be used.

Drug: General anesthesia group: induction propofol 1.5-2mg/kg and fentanyl 1-3g/kg, maintained with isoflurane or sevoflurane; Genetic: Blood test; Other: Lumbar spinal tap; Behavioral: Montreal Cognitive Assessment (MOCA) and MMSE

Interventions

Spinal anesthesia group: bupivacaine 10-15mg DRUG

Spinal anesthesia group

General anesthesia group: induction propofol 1.5-2mg/kg and fentanyl 1-3g/kg, maintained with isoflurane or sevoflurane DRUG

General anesthesia group

Blood test GENETIC

DNA will be tested for the presence of ε4 allele of the apolipoprotein E gene

General anesthesia group; Spinal anesthesia group

Lumbar spinal tap OTHER

1ml of cerebrospinal fluid (CSF) removed and stored for further analysis of amyloid tau protein after completion of the study

General anesthesia group; Spinal anesthesia group

Montreal Cognitive Assessment (MOCA) and MMSE BEHAVIORAL

General anesthesia group; Spinal anesthesia group

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• \>65 yrs of age
• Male or female
• Scheduled to undergo urologic procedures (e.g., transurethral resection of prostate, transurethral resection of bladder tumor), orthopedic (e.g., total knee replacement, total hip replacement) general (e.g., femoral hernia repair, lower abdominal surgery) or vascular surgery procedures (e.g. lower limb reperfusion amputations) and qualifies to be randomized to receive either local (spinal) or general anesthetic

You may not qualify if:

• Diagnosis of severe dementia
• Diagnosis of any other significant neurological disease such as Parkinson's, multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma followed by persistent neurologic defaults or known structural brain or spinal abnormalities.

Sponsors & Collaborators

• University Health Network, Toronto: lead

Study Sites (3)

Toronto General Hospital, University Health Network

Toronto, Ontario, M5G 2C4, Canada

Location

William Osler Health Centre

Toronto, Ontario, M9V 1R8, Canada

Location

Pauls Stradins Clinical University Hospital

Riga, LV 1002, Latvia

Location

MeSH Terms

Conditions

Alzheimer Disease; Dementia

Interventions

Fentanyl; Isoflurane; Sevoflurane; Hematologic Tests; Spinal Puncture; Mental Status and Dementia Tests

Condition Hierarchy (Ancestors)

Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Piperidines; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds; Methyl Ethers; Ethers; Organic Chemicals; Hydrocarbons, Fluorinated; Hydrocarbons, Halogenated; Hydrocarbons; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques; Biopsy; Specimen Handling; Diagnostic Techniques, Neurological; Punctures; Therapeutics; Surgical Procedures, Operative; Neuropsychological Tests; Psychological Tests; Behavioral Disciplines and Activities

Study Officials

• George Djaiani, MD

  Toronto General Hospital, University Health Network

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: The proposed study will be a prospective, multicenter, cluster randomization clinical trial comparing two different anesthetic techniques in elderly patients (\> 65 years of age) undergoing urology/orthopedic/general surgery. The study will follow a cluster design; patients undergoing orthopedic or vascular surgery will have spinal anesthesia, where standard practice. Patients undergoing urology or general surgery will receive general anesthesia, also where it is standard practice. Patients with severe dementia will be excluded.

Study Record Dates

• First Submitted: July 11, 2013
• First Posted: July 19, 2013
• Study Start: March 1, 2014
• Primary Completion: November 1, 2019
• Study Completion: July 1, 2023
• Last Updated: December 5, 2022

Record last verified: 2022-12

Locations

LA (1); CA (2)